Aberrant DNA methylation patterns in microsatellite stable human colorectal cancers define a new marker panel for the CpG island methylator phenotype

URN to cite this document:: urn:nbn:de:bvb:355-epub-508412
DOI to cite this document:: 10.5283/epub.50841

Gebhard, Claudia

; Mulet‐Lazaro, Roger ; Glatz, Dagmar ; Schwarzfischer‐Pfeilschifter, Lucia ; Schirmacher, Peter ; Gaedcke, Jochen ; Weichert, Wilko ; Reuschel, Edith ; Dietmaier, Wolfgang ; Rehli, Michael

Preview

License: Creative Commons Attribution Non-commercial No Derivatives 4.0
PDF - Published Version
Early View
(1MB)

Date of publication of this fulltext: 21 Oct 2021 06:23

Alternative links to fulltext:DOI Publisher

This publication is part of the DEAL contract with Wiley.

Details

Preview: Early View

Indexed in

Export bibliographical data

Abstract

A distinct group of colorectal carcinomas (CRCs) referred to as the "CpG island methylator phenotype" (CIMP) shows an extremely high incidence of de novo DNA methylation and may share common pathological, clinical or molecular features. However, there is limited consensus about which CpG islands (CGIs) define a CIMP, particularly in microsatellite stable (MSS) carcinomas. To study this phenotype ...